Methamphetamine and prescription amphetamines share important pharmacological properties, but differences in chemical structure, dosing, delivery, and medical supervision can profoundly affect their risks. This episode compares methamphetamine, Adderall, and Ritalin through the lens of neurotransmitter activity and clinical pharmacology. We also explore why methamphetamine itself retains a limited legitimate medical role despite its association with severe addiction.